Publications

Warner C. Greene, MD, PhDKeppler OT, Allespach I, Schüller L, Fenard D, Greene WC, Fackler OT. Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. J Virol. 2005 Feb; 79(3):1655-65. View in: PubMed
Warner Greene, MD, PhDHost factors regulating post-integration latency of HIV. View in: PubMed
Warner C. Greene, MD, PhDStopak K, Greene WC. Protecting APOBEC3G: a potential new target for HIV drug discovery. Curr Opin Investig Drugs. 2005 Feb; 6(2):141-7. View in: PubMed
Warner Greene, MD, PhDProtecting APOBEC3G: a potential new target for HIV drug discovery. View in: PubMed
Warner C. Greene, MD, PhDYonezawa A, Cavrois M, Greene WC. Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. J Virol. 2005 Jan; 79(2):918-26. View in: PubMed
Warner Greene, MD, PhDRodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. View in: PubMed
Warner C. Greene, MD, PhDCavrois M, Neidleman J, Yonemoto W, Fenard D, Greene WC. HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion. Virology. 2004 Oct 10; 328(1):36-44. View in: PubMed
Warner Greene, MD, PhDStudies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. View in: PubMed
Warner C. Greene, MD, PhDGreene WC. The brightening future of HIV therapeutics. Nat Immunol. 2004 Sep; 5(9):867-71. View in: PubMed
Warner Greene, MD, PhDHIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion. View in: PubMed